Cargando…
Dysregulation and implications of N6-methyladenosine modification in renal cell carcinoma
Increasing evidence indicates that N(6)-methyladenosine (m(6)A) methylation modification serves important functions in biological metabolism. Dysregulation of m(6)A regulators is related to the progression of different malignancies, including renal cell carcinoma (RCC). Recent studies have reported...
Autores principales: | Wu, Yaohai, Zhang, Shiqiang, Chen, Chujie, Pang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487297/ https://www.ncbi.nlm.nih.gov/pubmed/37692138 http://dx.doi.org/10.1097/CU9.0000000000000135 |
Ejemplares similares
-
Transcription factor E3 renal cell carcinoma presenting as secondary hypertension
por: Mukendi, Alain Mwamba, et al.
Publicado: (2023) -
Significance of timing of therapeutic line on effectiveness of nivolumab for metastatic renal cell carcinoma
por: Teishima, Jun, et al.
Publicado: (2023) -
Current laser therapy options for endoscopic treatment of upper tract urothelial carcinoma
por: Zollinger, Benjamin W., et al.
Publicado: (2023) -
Repeated exposure to fractional CO(2) laser delays squamous cell carcinoma formation and prevents clinical and subclinical photodamage visualized by line‐field confocal optical coherence tomography and histology
por: Olesen, Uffe H., et al.
Publicado: (2022) -
Laser therapy as a treatment for chronic radiation fibrosis
por: Wilson, Britney, et al.
Publicado: (2022)